100 related articles for article (PubMed ID: 15331911)
1. Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis.
Latorre M; Bartolomé-Nebreda JM; García-López MT; González-Muñiz R; Herranz R; Del Río J; Cenarruzabeitia E
Pharmacology; 2004 Oct; 72(2):68-76. PubMed ID: 15331911
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
Ballaz S; Barber A; Fortuño A; Del Río J; Martin-Martínez M; Gómez-Monterrey I; Herranz R; González-Muñiz R; García-López MT
Br J Pharmacol; 1997 Jun; 121(4):759-67. PubMed ID: 9208145
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.
Martín-Martínez M; Bartolomé-Nebreda JM; Gómez-Monterrey I; González-Muñiz R; García-López MT; Ballaz S; Barber A; Fortuño A; Del Río J; Herranz R
J Med Chem; 1997 Oct; 40(21):3402-7. PubMed ID: 9341915
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
[TBL] [Abstract][Full Text] [Related]
5. CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon.
Fornai M; Colucci R; Antonioli L; Baschiera F; Ghisu N; Tuccori M; Gori G; Blandizzi C; Del Tacca M
Eur J Pharmacol; 2007 Feb; 557(2-3):212-20. PubMed ID: 17208221
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini.
Tashiro M; Hirohata Y; Kihara Y; Akiyama T; Otsuki M
Pancreas; 1999 Mar; 18(2):156-64. PubMed ID: 10090413
[TBL] [Abstract][Full Text] [Related]
7. Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus.
Dal Forno G; Pietra C; Urciuoli M; van Amsterdam FT; Toson G; Gaviraghi G; Trist D
J Pharmacol Exp Ther; 1992 Jun; 261(3):1056-63. PubMed ID: 1602372
[TBL] [Abstract][Full Text] [Related]
8. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
9. Role of CCK and potential utility of CCK1 receptor antagonism in the treatment of pancreatitis induced by biliary tract obstruction.
Barrett TD; Yan W; Freedman JM; Lagaud GJ; Breitenbucher JG; Shankley NP
Br J Pharmacol; 2008 Apr; 153(8):1650-8. PubMed ID: 18297100
[TBL] [Abstract][Full Text] [Related]
10. A further analysis of the contraction induced by activation of cholecystokinin A receptors in guinea pig isolated ileum longitudinal muscle-myenteric plexus.
Corsi M; Palea S; Pietra C; Oliosi B; Gaviraghi G; Sugg E; Van Amsterdam FT; Trist DG
J Pharmacol Exp Ther; 1994 Aug; 270(2):734-40. PubMed ID: 7520941
[TBL] [Abstract][Full Text] [Related]
11. The effect of a cholecystokinin receptor antagonist lorglumid on the proteinase-antiproteinase balance in taurocholate acute experimental pancreatitis (AEP) in rats.
Kosidło S; Rydzewska G; Gabryelewicz A
Mater Med Pol; 1992; 24(4):223-6. PubMed ID: 1308047
[TBL] [Abstract][Full Text] [Related]
12. 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.
Morton MF; Barrett TD; Yan W; Freedman JM; Lagaud G; Prendergast CE; Moreno V; Pyati J; Figueroa K; Li L; Wu X; Rizzolio M; Breitenbucher JG; McClure K; Shankley NP
J Pharmacol Exp Ther; 2007 Nov; 323(2):562-9. PubMed ID: 17684117
[TBL] [Abstract][Full Text] [Related]
13. The role of cholecystokinin in the pathogenesis of acute pancreatitis in the isolated pancreas preparation.
Nordback IH; Clemens JA; Cameron JL
Surgery; 1991 Mar; 109(3 Pt 1):301-6. PubMed ID: 1705726
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
Wang SX
Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):443-6. PubMed ID: 8010038
[TBL] [Abstract][Full Text] [Related]
15. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
González-Puga C; García-Navarro A; Escames G; León J; López-Cantarero M; Ros E; Acuña-Castroviejo D
J Pineal Res; 2005 Oct; 39(3):243-50. PubMed ID: 16150104
[TBL] [Abstract][Full Text] [Related]
16. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
17. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structural modifications at the tryptophan domain.
Bartolomé-Nebreda JM; Gómez-Monterrey I; García-López MT; González-Muñiz R; Martín-Martínez M; Ballaz S; Cenarruzabeitia E; LaTorre M; Del Río J; Herranz R
J Med Chem; 1999 Nov; 42(22):4659-68. PubMed ID: 10579828
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
Taniguchi H; Yazaki N; Endo T; Nagasaki M
Eur J Pharmacol; 1996 May; 304(1-3):147-54. PubMed ID: 8813597
[TBL] [Abstract][Full Text] [Related]
19. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
[TBL] [Abstract][Full Text] [Related]
20. Effects of early decompression and cholecystokinin inhibition in rats with acute pancreatitis induced by bile-pancreatic-duct obstruction.
de Dios I; Urunuela A; Manso M
J Lab Clin Med; 2003 Apr; 141(4):265-71. PubMed ID: 12677172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
